Evidence map›Paper›PMID 33421609›Full record

ArticleRespiratory physiology & neurobiology2021

Angiotensin converting enzyme inhibition improves cerebrovascular control during exercise in male rats with heart failure.

Alec L E Butenas, Trenton D Colburn, Dryden R Baumfalk, Carl J Ade, K Sue Hageman, Steven W Copp, David C Poole, Timothy I Musch

Open access · greenAbstract read
In one paragraph

Article in Respiratory physiology & neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Thromboxane APhysiological reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alec L E ButenasDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States.
Trenton D ColburnDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States.
Dryden R BaumfalkDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States.
Carl J AdeDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States.
K Sue HagemanDepartment of Anatomy and Physiology, Kansas State University, Manhattan, KS, United States.
Steven W CoppDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States.
David C PooleDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States; Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, United States.
Timothy I MuschDepartment of Kinesiology, Kansas State University, Manhattan, KS, United States; Department of Anatomy and Physiology, Kansas State University, Manhattan, KS, United States. Electronic address: musch@vet.k-state.edu.
Kansas State University · US

Funding

Exercise Pressor Reflex Dysfunction in Heart Failure: Mechanisms and TreatmentR01HL142877 · NHLBI · KANSAS STATE UNIVERSITY · PI COPP, STEVEN W · 2018 to 2021
$1.2M
Aging, Chronic Disease and Skeletal Muscle PerfusionR21AG019228 · NIA · KANSAS STATE UNIVERSITY · PI MUSCH, TIMOTHY I · 2001 to 2002
$437k
NHLBI NIH HHS R01 HL142877NIA NIH HHS R21 AG019228
6 · The paper itself

Abstract

We investigated the effects of chronic (∼7 weeks) treatment with the angiotensin converting enzyme (ACE) inhibitor Captopril in rats with heart failure with reduced ejection fraction (HF-rEF) on brain blood flow (BF; radiolabeled microspheres) at rest and during submaximal exercise. We hypothesized that middle cerebral, posterior cerebral, and cerebellar BF during submaximal exercise (20 m/min, 5% incline) would be reduced in rats with HF-rEF (n = 10) compared to healthy (SHAM, n = 10) controls and HF-rEF rats chronically treated with Captopril (HF-rEF + Cap., n = 20). During submaximal exercise middle cerebral (HF-rEF + Cap.: 274 ± 12; HF-rEF: 234 ± 23; SHAM: 248 ± 24 ml/min/100 g) and cerebellar (HF-rEF + Cap.: 222 ± 14; HF-rEF: 243 ± 22; SHAM: 214 ± 23 ml/min/100 g) BF increased from rest in all groups with no difference among groups (P > 0.24). Posterior cerebral BF increased from rest in all groups but was lower than SHAM (394 ± 46 ml/min/100 g; P = 0.03) in HF-rEF (298 ± 19 ml/min/100 g) but not HF-rEF + Cap. (356 ± 18 ml/min/100 g; P = 0.14), supporting the concept that ACE inhibition in HF-rEF elevates brain BF increases, at least to the posterior cerebral region, during moderate intensity exercise/physical activity.

Indexed as

Angiotensin-Converting Enzyme InhibitorsAnimalsCaptoprilCerebrovascular CirculationDisease Models, AnimalElectrocardiographyHeart FailureMalePhysical Conditioning, AnimalRatsRats, Inbred LewAngiotensin-Converting Enzyme InhibitorsCaptoprilACEBrain blood flowCaptoprilCerebral blood flowHF-rEFSkeletal muscle

Identifiers

PMID33421609
PMCPMC7877948
OpenAlexW3118893290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.